简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

This Famed Company Is Working On A Potential Monkeypox Vaccine

2022-05-25 03:10

  • As cases of monkeypox continue to rise, Moderna Inc (NASDAQ:MRNA) is probably working on its platform towards finding a vaccine shot against the disease.
  • The company announced plans to explore potential vaccines for monkeypox at a "preclinical level," according to an announcement on Twitter.
  • Due to the similarity between the two diseases, the smallpox vaccine is effective against monkeypox. 
  • Unlike COVID-19, which spreads primarily through airborne transmission and the passing of tiny droplets, monkeypox is contracted through close physical contact. 
  • People who contract the disease often develop a contagious rash to the touch. 
  • Also Read: WHO Says Monkeypox Outbreak 'Unusual' But 'Containable'
  • Meanwhile, the World Health Organization does not believe the monkeypox outbreak outside of Africa requires mass vaccinations.
  • A senior official said that good hygiene and safe sexual behavior would help control its spread.
  • Germany's government said that it was assessing options for vaccinations, while Britain has offered them to some healthcare workers. 
  • Germany has ordered 40,000 doses of a Bavarian Nordic (OTC:BVNKF) vaccine to be ready to vaccinate contacts of those infected with monkeypox if an outbreak in Germany becomes more severe.
  • Price Action: MRNA shares are down 4.99% at $130.75 during the market session on the last check Tuesday.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。